Tato stránka byla automaticky přeložena a přesnost překladu není zaručena. Podívejte se prosím na anglická verze pro zdrojový text.

Podpora rozhodování pro dospělé, kteří čelí výměně pulzního generátoru implantovatelného kardioverteru-defibrilátoru

14. srpna 2026 aktualizováno: Ottawa Heart Institute Research Corporation

Hodnocení podpory rozhodování pro dospělé, kteří čelí výměně generátoru impulzů za implantabilní kardioverter-defibrilátor: Studie proveditelnosti

The implantable-cardioverter defibrillator (ICD) is a small medical device used to treat dangerously fast and potentially life-threatening heart rates. For patients at risk, the ICD can detect an abnormal rhythm and provide life-saving therapy by delivering a shock. ICD therapy has risks and benefits that should be weighed from each patient's perspective. An ICD battery needs to be surgically replaced 4 to 7 years to ensure ongoing function. At present, the majority of these batteries are automatically changed without eliciting patients' preferences. There is a need for a better way to engage with patients. Patients want to be involved in their healthcare decisions, yet more than half of patients with an ICD do not know that ICD replacement is optional. To ensure that patients are receiving treatment that they value and want, members of the interprofessional team should ensure that treatment decisions align with patients' expectations, values and preferences. This rests on the principle of shared decision making in which members of the healthcare team and patients deliberate together to arrive at a decision which best reflects the preferences and values of the patient. To facilitate the achievement of this goal, a patient decision aid (PDA) can be used. As a result, the investigators developed PDA for ICD replacement. The purpose of this feasibility trial is to collect preliminary data to test the feasibility of conducting a larger trial, and to evaluate the PDA for its acceptability and ease of use. Eligible and consented participants facing ICD replacement will be randomized to receive the decision aid or to usual care. The investigators will assess if this decision aid can improve participants' knowledge on ICD therapy and the replacement surgery, increase patients' perceived involvement in the decision, and determine whether their actual choice reflects their personal values.

Přehled studie

Detailní popis

Sudden cardiac death (SCD) due to a ventricular arrhythmia is a serious cause of cardiovascular death in Canada. The implantable cardioverter defibrillator (ICD) can reduce the incidence of SCD in high-risk patients by delivering an internal shock to restore a normal rhythm. The life expectancy of an ICD generator is estimated between four and seven years, and must be surgically replaced to ensure ongoing function. Implantable cardioverter-defibrillator (ICD) replacement is becoming increasingly common constituting nearly 40% of all ICD procedures. For the most part, ICDs are automatically replaced. With every ICD replacement, the net benefit of continued ICD therapy should be assessed individually in view of the procedural risks, inappropriate shocks, psychological risks, changes in health status, and the potential for harm and suffering at end-of-life. Some studies have shown that the mortality benefit of an ICD attenuates with advancing age and comorbidities.

There are many legitimate reasons for declining ICD generator replacement. The chronic nature of a cardiac condition and/or the diagnosis of a life-limiting disease since initial implantation may compel a patient to reconsider their health care goals from supporting quantity of life, to prioritizing one of quality. This is an important distinction as the ICD can prolong the dying process by delivering shock(s) which can result in pain and discomfort for the patient, and helplessness for witnesses. Other patients have reported psychological distress, while others report only truly understanding the effects of living with an ICD after receiving one, possibly leading to changes in treatment preference when they are faced with the decision to replace. Also, the replacement procedure includes a substantially greater risk for infection and reoperation as compared to the initial implantation.

These complexities warrant decision support to prepare patients to make decisions. Yet, no means exists to support patients' decision-making in the context of ICD replacement. A decision support intervention (including a patient decision aid with decision coaching) was developed using a user-centered design with various stakeholders and potential end-users, which could moderate treatment related uncertainty and prepare patients to make high quality decisions that are informed and based on their personal preferences and values.

Objectives:

  1. Conduct a pilot randomized controlled trial (RCT) to determine the feasibility of conducting a larger trial.
  2. To determine the effect of the decision support intervention for adults faced with ICD replacement on attributes of decision quality and decision-making processes

Typ studie

Intervenční

Zápis (Aktuální)

30

Fáze

  • Nelze použít

Kontakty a umístění

Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.

Studijní místa

    • Ontario
      • Ottawa, Ontario, Kanada, K1Y 4W7
        • University of Ottawa Heart Institute

Kritéria účasti

Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.

Kritéria způsobilosti

Věk způsobilý ke studiu

18 let a starší (Dospělý, Starší dospělý)

Přijímá zdravé dobrovolníky

Ne

Pohlaví způsobilá ke studiu

Všechno

Popis

Inclusion Criteria:

  • ICD battery nearing depletion or at elective replacement indicator
  • Able to speak and read in English
  • Able to provide informed consent; or if incapable of providing informed consent, can be obtained by the patient's appointed substitute decision-maker or power of attorney for personal care.

Exclusion Criteria:

  • Participants and/or substitute decision maker unable to understand the patient decision aid or decision coaching session due to language barrier or visual impairment
  • Participants with cardiac resynchronization therapy (CRT) or participants eligible for an upgrade to CRT.
  • Participants with conduction system disease who are pacemaker dependent

Studijní plán

Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.

Jak je studie koncipována?

Detaily designu

  • Primární účel: Výzkum zdravotnických služeb
  • Přidělení: Randomizované
  • Intervenční model: Paralelní přiřazení
  • Maskování: Singl

Zbraně a zásahy

Skupina účastníků / Arm
Intervence / Léčba
Experimentální: Decision support

The decision support intervention includes a patient decision and a decision coaching session. The patient decision aid includes a summary about the ICD's function, and the risks and benefits (including probabilities) associated with the option of replacing or not replacing the ICD. The decision coaching session will be led by a trained, non-directive decision coach who will provide support that aims to develop patients' skills in thinking about the options, assess their values associated with each option, and prepare them to discuss the decision in a consultation with their physician. The final decision, whether to replace or not replace the ICD, will be made with their treating physician (e.g., cardiologist, electrophysiologist).

The decision support intervention includes a patient decision and a decision coaching session. The patient decision aid includes a summary about the ICD's function, and the risks and benefits (including probabilities) associated with the option of replacing or not replacing the ICD. The decision coaching session will be led by a trained, non-directive decision coach who will provide support that aims to develop patients' skills in thinking about the options, assess their values associated with each option, and prepare them to discuss the decision in a consultation with their physician. The final decision, whether to replace or not replace the ICD, will be made with their treating physician (e.g., cardiologist, electrophysiologist).

Žádný zásah: Usual care

The control group will not receive the decision support intervention prior to consultation with the physician.

Co je měření studie?

Primární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Pilot RCT (Feasibility Measure): Participant Referral/Recruitment Rate.
Časové okno: Baseline to 12 months
Baseline to 12 months
Pilot RCT (Feasibility Measure): Completion of Decision Support Intervention
Časové okno: Baseline to 6 months

In this feasibility RCT, the feasibility regarding key processes to the success of a larger trial will be assessed. The investigators will descriptively collect the rate of participants who complete the decision support intervention.

Baseline to 6 months
Percentage of Participants With Missing Questionnaires
Časové okno: Baseline to 6 months

The percentage of participants with missing questionnaire data is reported.

Baseline to 6 months

Sekundární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Knowledge
Časové okno: Measured at 2-4 week Follow Up

The investigators developed a knowledge test based on the content of the patient decision aid. It was endorsed for validity by the Patient Decision Aid (PtDA) development team using a standardized template in the form of true or false questions. There are six questions meant to assess a patient's understanding of their heart condition, treatment options, and risks and benefits of each option. Reported scores are the mean percentage of correctly answered questions from the knowledge based test.

Measured at 2-4 week Follow Up
Decisional Conflict
Časové okno: 1 month, 6 months, 12 months follow-up

The Decisional Conflict Scale measures a person's perception of the difficulty in making a decision, the extent to which they feel uncertain about treatment options, are knowledgeable about the risks and benefits of options, clear about personal values, and supported in decision making. The scale has good test-retest reliability (Cronbach's alpha coefficients > 0.78) and predictive validity.

The scores for each item range from 0-4. The scores for all items are summed, then divided by 16 and multiplied by 25. Total scores range from 0 (no decisional conflict) to 100 (extremely high decisional conflict).

Scores lower than 25 are associated with decision implementation and scores higher than 37.5 are associated with delayed decisions.

1 month, 6 months, 12 months follow-up
Preferred Option
Časové okno: Assessed at 2-4 weeks

Preferred option will be measured by asking patients whether they prefer to have their ICD's pulse generator replaced, not replaced, or whether they are unsure using the 15-point Choice Predisposition Scale that demonstrates a patient's inclination toward a given option. This scale has a test-retest coefficient >0.90.

Score scale 1-15 with lower scores indicating a preference to not replacing the ICD, and high scores toward replacing.

Assessed at 2-4 weeks
Perceptions of Involvement in Decision-making at 6Months
Časové okno: at 6 month follow up

This will be measured using a modified version of Strull, Lo, & Charles's (1984) role in decision-making survey. Five statements rest along the continuum of how decisions can be made between patients and providers. Participants must select the statement that best represents their perceived involvement in the final decision.

Results are cumulative across timepoints.

at 6 month follow up
Perceptions of Involvement in Decision-making at 12Months
Časové okno: at 12 month follow up

This will be measured using a modified version of Strull, Lo, & Charles's (1984) role in decision-making survey. Five statements rest along the continuum of how decisions can be made between patients and providers. Participants must select the statement that best represents their perceived involvement in the final decision.

Results are cumulative across timepoints.

at 12 month follow up
The Medical Outcomes Trust Short Form (SF-36v2)
Časové okno: Baseline visit intervention and usual care groups

The SF-36 is a reliable and valid generic health related quality of life scale (HRQL) comprised of 36 items. Associations between HRQL and decision choice will be made.

Score ranges from 0 to 100. Higher scores indicate better perception of health.

Baseline visit intervention and usual care groups
Acceptability and Usability of Patient Decision Aid
Časové okno: 1 month; intervention group only

Intervention group participants will be asked common acceptability and usability questions extensively used for evaluating PtDAs during development (Barry, Cherkin, Chang, Fowler, & Skates, 1997; Kushniruk & Patel, 2004; O'Connor & Cranney, 2002).

Results are reported as the number of participants selecting the highest acceptability for each category with the most positive answer in parenthesis in the row title.

1 month; intervention group only
Participant Satisfaction With Decision Coaching
Časové okno: 1 month; intervention group only

Patients' satisfaction with decision coaching will be measured using the Genetic Counseling Satisfaction Scale and perceptions of decision coach neutrality (Schwalm, Stacey, Pericak, & Natarajan, 2012; Tercyak, Johnson, Roberts, & Cruz, 2001). This scale has face validity and a reliability coefficient of alpha 0.80 to 0.90 in genetic counselling contexts with adults.

Results are reported as number of participants that rated the highest satisfaction for each question, with the most positive response in parentheses in the row name.

1 month; intervention group only

Další výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Actual Choice at 6months
Časové okno: 6 month followup; intervention and usual care groups

The number of participants who chose to accept ICD replacement, or decline ICD replacement. Only participants that were required to make a final decision and procedure dates occurred at the 6 month timeline.

6 month followup; intervention and usual care groups
Actual Choice at 12months
Časové okno: 12 month followup; intervention and usual care groups

The number of participants who chose to accept ICD replacement or decline ICD replacement. Results include only those participants required to make a final decision, with procedure dates up to the 12month follow-up. Note that the results at 12months include those at 6months as cumulative data.

12 month followup; intervention and usual care groups
Survival
Časové okno: 6 months, 12 months; intervention and usual care groups14

The number of participants who are alive or dead at 6 months and 12months.

6 months, 12 months; intervention and usual care groups14

Spolupracovníci a vyšetřovatelé

Zde najdete lidi a organizace zapojené do této studie.

Vyšetřovatelé

  • Ředitel studie: Dawn Stacey, RN, PhD, University of Ottawa; Ottawa Hospital Research Institute

Publikace a užitečné odkazy

Osoba odpovědná za zadávání informací o studiu tyto publikace poskytuje dobrovolně. Mohou se týkat čehokoli, co souvisí se studiem.

Termíny studijních záznamů

Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.

Hlavní termíny studia

Začátek studia

1. dubna 2016

Primární dokončení (Aktuální)

1. dubna 2018

Dokončení studie (Aktuální)

1. října 2018

Termíny zápisu do studia

První předloženo

15. ledna 2016

První předloženo, které splnilo kritéria kontroly kvality

26. ledna 2016

První zveřejněno (Odhadovaný)

29. ledna 2016

Aktualizace studijních záznamů

Poslední zveřejněná aktualizace (Aktuální)

9. listopadu 2026

Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality

14. srpna 2026

Naposledy ověřeno

1. dubna 2022

Více informací

Termíny související s touto studií

Plán pro data jednotlivých účastníků (IPD)

Plánujete sdílet data jednotlivých účastníků (IPD)?

NE

Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .

Předplatit